2-118108296-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016133.4(INSIG2):c.652A>T(p.Ile218Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,595,600 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016133.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INSIG2 | NM_016133.4 | c.652A>T | p.Ile218Phe | missense_variant | 6/6 | ENST00000245787.9 | NP_057217.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INSIG2 | ENST00000245787.9 | c.652A>T | p.Ile218Phe | missense_variant | 6/6 | 1 | NM_016133.4 | ENSP00000245787.4 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000256 AC: 60AN: 234340Hom.: 0 AF XY: 0.000353 AC XY: 45AN XY: 127376
GnomAD4 exome AF: 0.000151 AC: 218AN: 1443288Hom.: 1 Cov.: 27 AF XY: 0.000220 AC XY: 158AN XY: 718382
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152312Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2024 | The c.652A>T (p.I218F) alteration is located in exon 6 (coding exon 5) of the INSIG2 gene. This alteration results from a A to T substitution at nucleotide position 652, causing the isoleucine (I) at amino acid position 218 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at